BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Minami K, Tamano R, Kasai E, Oyama H, Hasegawa M, Shinohara S, Asaki T. Effects of duloxetine on pain and walking distance in neuropathic pain models via modulation of the spinal monoamine system. Eur J Pain 2018;22:355-69. [DOI: 10.1002/ejp.1125] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Tang S, Jing H, Huang Z, Huang T, Lin S, Liao M, Zhou J. Identification of key candidate genes in neuropathic pain by integrated bioinformatic analysis. J Cell Biochem 2020;121:1635-48. [DOI: 10.1002/jcb.29398] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
2 Onda A, Kimura M. Reduction in anxiety during treatment with exercise and duloxetine is related to improvement of low back pain-related disability in patients with non-specific chronic low back pain. Fukushima J Med Sci 2020;66:148-55. [PMID: 33298637 DOI: 10.5387/fms.2020-22] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Yoneda S, Kasai E, Matsuo M, Tamano R, Sakurai Y, Asaki T, Fujita M. Duloxetine ameliorates the impairment of diffuse noxious inhibitory control in rat models of peripheral neuropathic pain and knee osteoarthritis pain. Neurosci Lett 2020;729:134990. [PMID: 32315711 DOI: 10.1016/j.neulet.2020.134990] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
4 Nakajima H, Watanabe S, Honjoh K, Kubota A, Matsumine A. Symptom-based pharmacotherapy for neuropathic pain related to spinal disorders: results from a patient-based assessment. Sci Rep 2022;12:7192. [PMID: 35504949 DOI: 10.1038/s41598-022-11345-y] [Reference Citation Analysis]
5 Bouchenaki H, Bégou M, Magy L, Hajj R, Demiot C. Les traitements pharmacologiques des douleurs neuropathiques. Therapies 2019;74:633-43. [DOI: 10.1016/j.therap.2019.04.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
6 Govil N, Parag K, Arora P, Khandelwal H, Singh A; Ruchi. Perioperative duloxetine as part of a multimodal analgesia regime reduces postoperative pain in lumbar canal stenosis surgery: a randomized, triple blind, and placebo-controlled trial. Korean J Pain 2020;33:40-7. [PMID: 31888316 DOI: 10.3344/kjp.2020.33.1.40] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
7 Singh R, Rao HK, Singh TG. Neuropathic pain in diabetes mellitus: Challenges and future trends. Obesity Medicine 2020;18:100215. [DOI: 10.1016/j.obmed.2020.100215] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
8 Sakurai Y, Fujita M, Kawasaki S, Sanaki T, Yoshioka T, Higashino K, Tofukuji S, Yoneda S, Takahashi T, Koda K, Asaki T, Hasegawa M, Morioka Y. Contribution of synovial macrophages to rat advanced osteoarthritis pain resistant to cyclooxygenase inhibitors. Pain 2019;160:895-907. [PMID: 30585984 DOI: 10.1097/j.pain.0000000000001466] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 8.3] [Reference Citation Analysis]
9 Otsuki S, Okamoto Y, Ikeda K, Wakama H, Okayoshi T, Neo M. Perioperative duloxetine administration reduces pain after high tibial osteotomy and non-steroidal anti-inflammatory administration: A prospective, controlled study. Knee 2022;38:42-9. [PMID: 35908360 DOI: 10.1016/j.knee.2022.07.006] [Reference Citation Analysis]